Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

242.81 -2.18 (-0.89%)
Streaming Delayed Price Updated: 12:28 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ResMed Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
1 Large-Cap Stock to Target This Week and 2 We Brush Off
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an... 
Via StockStory
News headline image
Discover which S&P500 stocks are making waves on Friday. ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? ↗
ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader. 
Via The Motley Fool
News headline image
1 S&P 500 Stock to Research Further and 2 We Turn Down
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
Earnings Scheduled For October 30, 2025 ↗
 
Via Benzinga
News headline image
ResMed Inc. (NYSE:RMD) Offers a Compelling Dividend Profile Supported by Strong Profitability ↗
ResMed (RMD) offers a reliable dividend with strong growth potential. Its low payout ratio, high profitability, and financial health support future dividend increases. 
Via Chartmill
News headline image
ResMed’s Q3 Earnings Call: Our Top 5 Analyst Questions
ResMed’s third quarter results aligned with Wall Street’s revenue expectations, while its non-GAAP earnings per share moderately outpaced consensus. Management attributed the quarter’s performance to... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Nvidia To Rally Around 73%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday? ↗
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive. 
Via Benzinga
News headline image
Gapping S&P500 stocks in Friday's session ↗
Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
News headline image
RMD Q3 Deep Dive: ResMed Launches New Mask Platform and Invests in U.S. Operations
Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above... 
Via StockStory
Topics Economy
News headline image
These S&P500 stocks are moving in today's after hours session ↗
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
Resmed Inc (NYSE:RMD) Reports Q1 FY2026 Results: Mixed Earnings Beat Fails to Prevent Stock Decline ↗
Resmed's Q1 FY2026 earnings met expectations with $1.34B revenue and $2.55 EPS. Despite strong profit growth and margin expansion, the stock traded lower post-announcement. 
Via Chartmill
Topics Earnings
News headline image
ResMed (NYSE:RMD) Reports Q3 In Line With Expectations
Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above... 
Via StockStory
News headline image
Insights into ResMed's Upcoming Earnings ↗
 
Via Benzinga
News headline image
ResMed (RMD) Reports Q3: Everything You Need To Know Ahead Of Earnings
Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
ResMed Inc (NYSE:RMD) Stands Out as a Quality Investment with Strong Financials ↗
ResMed is a top-quality digital health stock with strong revenue growth, high profitability, and excellent cash flow conversion, making it a standout for long-term investors. 
Via Chartmill
News headline image
1 Healthcare Stock to Research Further and 2 We Ignore
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
News headline image
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome... 
Via Benzinga
Topics Economy
News headline image
What 9 Analyst Ratings Have To Say About ResMed ↗
 
Via Benzinga
News headline image
SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
ResMed Inc. (NYSE:RMD): A Dividend Stock with Strong Profitability and Financial Health ↗
ResMed (RMD) is a reliable dividend stock with strong growth, high profitability, and a robust financial condition, ensuring sustainable payouts. 
Via Chartmill
News headline image
2 Unpopular Stocks That Deserve a Second Chance and 1 That Underwhelm
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
News headline image
Heylo Appoints First CEO, Poised for Revolution in Remote Disability Support
Cincinnati-based startup Heylo has announced a significant stride in its mission to revolutionize care for individuals with intellectual and developmental disabilities (I/DD) with the appointment of... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the... 
Via MarketMinute
News headline image
2 Cash-Heavy Stocks to Research Further and 1 We Turn Down
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Topics Electric Vehicles World Trade
News headline image
2 Cash-Heavy Stocks with Solid Fundamentals and 1 We Brush Off
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
Topics Electric Vehicles World Trade
News headline image
2 Safe-and-Steady Stocks with Exciting Potential and 1 That Underwhelm
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
News headline image
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential... 
Via StockStory
Topics World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.